2.40

2.04% -0.05

Silo Pharma Inc (SILO)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$2.45

Aprire:

$2.45

Volume 24 ore:

35,479

Relative Volume:

0.19

Capitalizzazione di mercato:

$3.81M

Reddito:

$72,100

Utile/perdita netta:

$-4.84M

Rapporto P/E:

-0.3219

EPS:

-7.4566

Flusso di cassa netto:

$-3.84M

1 W Prestazione:

-5.51%

1M Prestazione:

-47.83%

6M Prestazione:

-55.54%

1 anno Prestazione:

-73.36%

Intervallo 1D:

$2.205

$2.50

Intervallo di 1 settimana:

$2.205

$2.56

Portata 52W:

$2.205

$15.15

Silo Pharma Inc Stock (SILO) Company Profile

Nome

Silo Pharma Inc

Settore

Healthcare (1074)

Industria

Biotechnology (600)

Telefono

(718) 400-9031

Indirizzo

677 N. WASHINGTON BLVD, SARASOTA

Dipendente

Cinguettio

Prossima data di guadagno

2026-08-12

Ultimi documenti SEC

SILO's Discussions on Twitter

Compare SILO vs PSNYW, GOODO, SHMD, DWLD, QQQE

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SILO SILO PHARMA INC	1.71	17.96M	0	0	0	0.00
PSNYW Polestar Automotive Holding Uk	5.00	394.14M	2.07B	-1.42B	-1.37B	-0.6765
GOODO Gladstone Commercial Corporation	20.92	372.90M	0	0	0	0.00
SHMD Schmid Group N V	3.15	315.90M	52.15M	-21.46M	0	-0.4675
DWLD Davis Select Worldwide ETF	47.39	0	0	0	0	0.00
QQQE Direxion NASDAQ-100 Equal Weigh	120.75	0	0	0	0	0.00

Silo Pharma Inc Borsa (SILO) Ultime notizie

Aug 20, 2026

Form 8K Silo Pharma Inc For: 19 August By Investing.com - Investing.com South Africa

Aug 20, 2026

Aug 19, 2026

Silo Pharma Acquires Digital Assets via Stock Issuance - TipRanks

Aug 19, 2026

Silo Pharma Acquires Software and IP From Parkview Consulting for 165,000 Shares - TradingView

Aug 19, 2026

Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting - TradingView

Aug 19, 2026

Silo Pharma Secures Canadian Patent Allowance for PTSD Treatment SPC-15 - citybuzz -

Aug 19, 2026

Aug 18, 2026

Silo Pharma receives Canadian patent allowance for SPC-15 drug By Investing.com - Investing.com Canada

Aug 18, 2026

Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment - The Manila Times

Aug 18, 2026

A PTSD treatment designed to build stress resilience gets Canadian patent allowance - Stock Titan

Aug 18, 2026

Silo (SILO) Technical Check: Adds 1.95% to Close at $3.13; Range and Risk: the $2.97 to $3.29 Range Remains in Focus in the Current UpdateSuperTrend - Vinanet

Aug 18, 2026

Aug 17, 2026

Silo Pharma Shareholders Approve Major Share Authorization Expansion - TipRanks

Aug 17, 2026

Silo Pharma (SILO) holders approve lifting share cap from 6.7M - Stock Titan

Aug 17, 2026

Aug 15, 2026

Silo Pharma (SILO) Slips 0.62% to $3.20 as Shares Consolidate Between Key Technical LevelsStock Picks - Vinanet

Aug 15, 2026

Aug 13, 2026

Silo Pharma (SILO) trims cash burn, mitigates going-concern risk in Q2 2026 - Stock Titan

Aug 13, 2026

Silo Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 13, 2026

Silo Pharma (SILO) investor group discloses 9.99% warrant-based ownership cap - Stock Titan

Aug 13, 2026

Aug 10, 2026

Silo Pharma receives European patent for SPC-15 PTSD treatment By Investing.com - Investing.com South Africa

Aug 10, 2026

Silo Pharma Granted European Patent Covering Novel PTSD Therapy - The Manila Times

Aug 10, 2026

Silo Pharma receives European patent for SPC-15 PTSD treatment - Investing.com India

Aug 10, 2026

Silo Pharma Announces European Patent Grant for SPC-15 PTSD Prevention Therapy - Quiver Quantitative

Aug 10, 2026

SILO Q4 2023 Earnings: EPS Misses Estimates, Stock Gains 1.2% Despite No RevenueCore Business Growth - vinanet.vn

Aug 10, 2026

Aug 07, 2026